TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
10.70
-0.50 (-4.46%)
At close: Sep 12, 2025, 4:00 PM EDT
10.82
+0.12 (1.12%)
After-hours: Sep 12, 2025, 7:59 PM EDT
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $8.92 million as of September 12, 2025. Its market cap has increased by 87.20% in one year.
Market Cap
8.92M
Enterprise Value
1.55M
1-Year Change
87.20%
Ranking
Category
Stock Price
$10.70
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $8.92M, a decrease of -81.36%. That is a compound annual growth rate of -33.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 8.92M | 280.18% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
| Jul 9, 2021 | 47.87M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.45B |
| Johnson & Johnson | 423.36B |
| AbbVie | 373.87B |
| UnitedHealth Group | 314.07B |
| AstraZeneca | 250.26B |
| Novo Nordisk | 244.96B |
| Novartis AG | 244.56B |
| Abbott Laboratories | 225.15B |